Trial
NCT03302247
Depletion of Myeloid Derived Suppressor Cells to Enhance Anti PD-1 Therapy
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Fox Chase Cancer Center
Collaborators
—
Condition
Non Small Cell Lung Cancer Stage IIIB
Intervention
Nivolumab
Why stopped
Unable to accrue subjects
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-10-28